UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy

Clinical epigenetics, 2020-10, Vol.12 (1), p.147-147, Article 147

2020

Volltextzugriff (PDF)

Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy

Clinical cancer research, 2012-03, Vol.18 (6), p.1611-1618

2012

Volltextzugriff (PDF)

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma

Blood, 2010-10, Vol.116 (17), p.3268-3277

2010

Volltextzugriff (PDF)

CXCR4 upregulation is an indicator of sensitivity to B-cell receptor/PI3K blockade and a potential resistance mechanism in B-cell receptor-dependent diffuse large B-cell lymphomas

Haematologica (Roma), 2020-05, Vol.105 (5), p.1361-1368

2020

Volltextzugriff (PDF)

FOXO1 activation is an effector of SYK and AKT inhibition in tonic BCR signal-dependent diffuse large B-cell lymphomas

Blood, 2016-02, Vol.127 (6), p.739-748

2016

Volltextzugriff (PDF)

SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma

Blood, 2008-02, Vol.111 (4), p.2230-2237

2008

Volltextzugriff (PDF)

Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity

Scientific reports, 2022-11, Vol.12 (1), p.19660-14, Article 19660

2022

Volltextzugriff (PDF)

A Specific CD44lo CD25lo Subpopulation of Regulatory T Cells Inhibits Anti-Leukemic Immune Response and Promotes the Progression in a Mouse Model of Chronic Lymphocytic Leukemia

Frontiers in immunology, 2022-02, Vol.13, p.781364-781364

2022

Volltextzugriff (PDF)

Inhibition of protein disulfide isomerase induces differentiation of acute myeloid leukemia cells

Haematologica (Roma), 2018-11, Vol.103 (11), p.1843-1852

2018

Volltextzugriff (PDF)

Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomas

Proceedings of the National Academy of Sciences - PNAS, 2007-02, Vol.104 (9), p.3207-3212

2007

Volltextzugriff (PDF)

FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy

Oncoimmunology, 2018-05, Vol.7 (5), p.e1423183-e1423183

2018

Volltextzugriff (PDF)

AP1-Dependent Galectin-1 Expression Delineates Classical Hodgkin and Anaplastic Large Cell Lymphomas from Other Lymphoid Malignancies with Shared Molecular Features

Clinical cancer research, 2008-06, Vol.14 (11), p.3338-3344

2008

Volltextzugriff (PDF)

Role of Autoantigen Induced-B-Cell Receptor Internalization and Its Inhibition for the Biology and Survival of Diffuse Large B-Cell Lymphoma (DLBCL) Cells

Blood, 2023-11, Vol.142 (Supplement 1), p.4141-4141

2023

Volltextzugriff (PDF)

Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia

Molecular medicine reports, 2015-05, Vol.11 (5), p.3948-3954

2015

Volltextzugriff (PDF)

MLL-Rearranged B Lymphoblastic Leukemias Selectively Express the Immunoregulatory Carbohydrate-Binding Protein Galectin-1

Clinical cancer research, 2010-04, Vol.16 (7), p.2122-2130

2010

Volltextzugriff (PDF)

Super enhancers as master gene regulators in the pathogenesis of hematologic malignancies

Biochimica et biophysica acta. Reviews on cancer, 2022-03, Vol.1877 (2), p.188697-188697, Article 188697

2022

Volltextzugriff (PDF)

PIM Kinases Regulate Super-Enhancer-Dependent Gene Expression in Diffuse Large B-Cell Lymphoma

Blood, 2022-11, Vol.140 (Supplement 1), p.3044-3045

2022

Volltextzugriff (PDF)

New insights into redox homeostasis as a therapeutic target in B-cell malignancies

Current opinion in hematology, 2017-07, Vol.24 (4), p.393-401

2017

Volltextzugriff (PDF)

Abstract 1018: SEL120, a CDK8/CDK19 inhibitor, possesses strong multilineage differentiation potential in AML

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.1018-1018

2021

Volltextzugriff (PDF)

MEN1703-Mediated PIM Kinases Inhibition Impairs Protumoral and Immunosuppressive Phenotype and Functions of Macrophages in Classical Hodgkin Lymphoma

Blood, 2022-11, Vol.140 (Supplement 1), p.6441-6442

2022

Volltextzugriff (PDF)

Immunoregulatory CD71+ Erythroid Cells (CECs) Expand in Multiple Myeloma and Impair Control of L. Monocytogenes Infection

Blood, 2022-11, Vol.140 (Supplement 1), p.12538-12539

2022

Volltextzugriff (PDF)

CD180 As a Putative Target for Immunotherapy in Aggressive Mature B Cell Lymphomas

Blood, 2022-11, Vol.140 (Supplement 1), p.10273-10274

2022

Volltextzugriff (PDF)

MiR-17-92 represses PTPROt and PP2A phosphatases and amplifies tonic BCR signaling in DLBCL cells

Experimental hematology, 2017-02, Vol.46, p.56-61.e1

2017

Volltextzugriff (PDF)

Human leukocyte antigens HLA DRB1 influence clinical outcome of chronic lymphocytic leukemia

Haematologica (Roma), 2007-05, Vol.92 (5), p.710-711

2007

Volltextzugriff (PDF)

1 – 25 von 128

Suche als RSS-Feed

Aktive Filter

ThemaCell Biology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(103)

Publikationsform

Artikel
(126)
Berichte
(2)

Sprache

Englisch
(126)
Japanisch
(10)
Polnisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Life Sciences & Biomedicine
(43)
Humans
(38)
Hematology
(23)
Oncology
(20)
Female
(15)
Cell Line, Tumor
(13)
Male
(12)
Apoptosis
(11)
Biological And Medical Sciences
(10)
Lymphoma, Large B-Cell, Diffuse - Genetics
(10)
Middle Aged
(10)
Signal Transduction
(10)
Animals
(9)
Gene Expression
(9)
Hematologic And Hematopoietic Diseases
(9)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(9)
Medical Sciences
(9)
Adult
(8)
Leukemia
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy

Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma

CXCR4 upregulation is an indicator of sensitivity to B-cell receptor/PI3K blockade and a potential resistance mechanism in B-cell receptor-dependent diffuse large B-cell lymphomas

FOXO1 activation is an effector of SYK and AKT inhibition in tonic BCR signal-dependent diffuse large B-cell lymphomas

SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma

Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity

A Specific CD44lo CD25lo Subpopulation of Regulatory T Cells Inhibits Anti-Leukemic Immune Response and Promotes the Progression in a Mouse Model of Chronic Lymphocytic Leukemia

Targeting the thioredoxin system as a novel strategy against B‐cell acute lymphoblastic leukemia

Inhibition of protein disulfide isomerase induces differentiation of acute myeloid leukemia cells

Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomas

FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy

AP1-Dependent Galectin-1 Expression Delineates Classical Hodgkin and Anaplastic Large Cell Lymphomas from Other Lymphoid Malignancies with Shared Molecular Features

Role of Autoantigen Induced-B-Cell Receptor Internalization and Its Inhibition for the Biology and Survival of Diffuse Large B-Cell Lymphoma (DLBCL) Cells

Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia

MLL-Rearranged B Lymphoblastic Leukemias Selectively Express the Immunoregulatory Carbohydrate-Binding Protein Galectin-1

Super enhancers as master gene regulators in the pathogenesis of hematologic malignancies

PIM Kinases Regulate Super-Enhancer-Dependent Gene Expression in Diffuse Large B-Cell Lymphoma

New insights into redox homeostasis as a therapeutic target in B-cell malignancies

Abstract 1018: SEL120, a CDK8/CDK19 inhibitor, possesses strong multilineage differentiation potential in AML

MEN1703-Mediated PIM Kinases Inhibition Impairs Protumoral and Immunosuppressive Phenotype and Functions of Macrophages in Classical Hodgkin Lymphoma

Immunoregulatory CD71+ Erythroid Cells (CECs) Expand in Multiple Myeloma and Impair Control of L. Monocytogenes Infection

CD180 As a Putative Target for Immunotherapy in Aggressive Mature B Cell Lymphomas

MiR-17-92 represses PTPROt and PP2A phosphatases and amplifies tonic BCR signaling in DLBCL cells

Human leukocyte antigens HLA DRB1 influence clinical outcome of chronic lymphocytic leukemia

Aktive Filter

Suchergebnisse filtern